Cytokinetics reported $106.24M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 436.58M 296.75M
Acorda Therapeutics ACOR:US USD 20.7M 2.43M
Amgen AMGN:US USD 9.5B 4.3B
Arca Biopharma ABIO:US USD 53.36M 13.57M
Bayer BAYN:GR EUR 4.36B 949M
Biogen BIIB:US USD 3.68B 1.03B
Brainstorm Cell Therapeutics BCLI:US USD 4.14M 4.86M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Capricor Therapeutics CAPR:US USD 46.61M 30.22M
Cytokinetics CYTK:US USD 106.24M 12.61M
Eisai 4523:JP JPY 264.53B 23.29B
Eli Lilly And LLY:US USD 2.62B 5.5M
Exelixis EXEL:US USD 675.29M 48.29M
Genocea Biosciences GNCA:US USD 20.14M 17.01M
Geron GERN:US USD 61.47M 14.59M
Halozyme Therapeutics HALO:US USD 147.16M 56.23M
Intra Cellular Therapies ITCI:US USD 135.36M 58.12M
Ligand Pharmaceuticals LGND:US USD 121.41M 116.13M
Novartis NOVN:VX USD 8.73B 5.1B
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Roche Holding ROG:VX 4.32B 2.54B